外敷骨痹散治疗膝骨性关节炎临床研究

Clinical observation on external application of Gubi Powder in treatment of knee osteoarthritis

目的观察骨痹散治疗膝骨性关节炎的临床疗效。方法将我院82例患者随机分为治疗组与对照组各41例,治疗组采用我院骨痹散外用治疗,对照组采用洛索洛芬钠凝胶膏外用治疗。观察两组治疗前后临床疗效、视觉模拟疼痛评分(VAS)、WOMAC骨关节炎指数评分(WOMAC)及检测肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)细胞因子的变化。结果治疗后,治疗组临床疗效显著高于对照组(P<0.05);治疗组血清细胞因子TNF-α、IL-β表达水平低于对照组(P<0.05);治疗组VAS疼痛评分及WOMAC功能评分均低于对照组(P<0.05)。结论骨痹散可明显改善膝骨性关节炎患者症状,降低患者炎性因子水平,对膝骨性关节炎治疗有良好的临床疗效。

Objective To observe the clinical efficacy of Gubi Powder on knee osteoarthritis(KOA).Methods Eightytwo patients with KOA were randomly divided into treatment group and control group,41 cases each.Treatment group received Gubi Powder,and control group received loxoprofen sodium gel ointment.The changs of Visual Analogue Scale(VAS)score,WOMAC Osteoarthritis Index(WOMAC)score,tumor necrosis factor-α(TNF-α)and interluekin(IL)-1β before and after treatment were compared between the two groups.Results After treatment,the clinical efficacy in treatment group was significantly better than in control group(P<0.05);serum TNF-αand IL-1β levels were significantly lower in treatment group than in control group(P<0.05);VAS score andWOMAC score were significantly lower in treatment group than in control group(P<0.05).Conclusion The clinical effect of Gubi Powder for treating knee osteoarthritis is better than loxoprofen gel ointment.